Long-Term Safety and Efficacy of Esketamine in Patients With Treatment-Resistant Depression: A Review of Interim Results From the SUSTAIN-3 Trial
Advertisement
Advertisement
Trending on AJMC
1
Medicaid Work Requirements Set to Leave Millions Without Insurance
2
COVID-19 Vaccination Linked to Lower Risk of Long COVID in Adolescents
3
Changing Tumor Classifications May Explain Rise in Early-Onset CRC
4
Remote Physiological Monitoring Improves Patient Access, Care, and Revenue
5
